2014
DOI: 10.1016/j.jcyt.2014.01.122
|View full text |Cite
|
Sign up to set email alerts
|

Potent polyclonal T cell activation and expansion through GMP-grade transact nano-matrices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Examples include MACS GMP TransAct CD3/CD28 beads (Miltenyi Biotec Inc.) [78], the Expamer platform (Juno Therapeutics) [79], phase-change hydrogel substrates coupled with agonistic antibodies (Quad Technologies) and other novel technologies (Table I).…”
Section: Alternative Cell-manufacturing Technologiesmentioning
confidence: 99%
“…Examples include MACS GMP TransAct CD3/CD28 beads (Miltenyi Biotec Inc.) [78], the Expamer platform (Juno Therapeutics) [79], phase-change hydrogel substrates coupled with agonistic antibodies (Quad Technologies) and other novel technologies (Table I).…”
Section: Alternative Cell-manufacturing Technologiesmentioning
confidence: 99%